HEPATOLOGY IN THE ERA OF MASLD: Fatty Liver Disease Diagnosis and Management.

★★★★★ 5.0 132 reviews

US$57.92
Price when purchased online
Free shipping Free 30-day returns

Sold and shipped by moulinduhamel.com
We aim to show you accurate product information. Manufacturers, suppliers and others provide what you see here.
US$57.92
Price when purchased online
Free shipping Free 30-day returns

How do you want your item?
You get 30 days free! Choose a plan at checkout.
Shipping
Arrives Aug 14
Free
Pickup
Check nearby
Delivery
Not available

Sold and shipped by moulinduhamel.com
Free 30-day returns Details

Product details

Management number 233476567 Release Date 2026/06/27 List Price US$57.92 Model Number 233476567
Category

A modern liver medicine reference should not feel outdated before it reaches your desk.Hepatology in the Era of MASLD gives clinicians, trainees, and advanced healthcare readers a structured guide to the new language, diagnostic pathways, risk stratification tools, and treatment landscape reshaping fatty liver care.Built around the transition from NAFLD and NASH to MASLD and MASH, this professional reference explains how metabolic dysfunction, steatotic liver changes, fibrosis risk, diabetes, cardiovascular disease, cirrhosis, hepatocellular carcinoma, lifestyle intervention, resmetirom, GLP-1 receptor agonists, and emerging therapies fit into contemporary practice. Rather than treating the topic as a narrow liver condition, it frames MASLD as a multisystem cardiometabolic problem that requires coordinated clinical reasoning. The book is especially useful for readers who need a clinically organized overview of a fast-changing field without losing depth, terminology accuracy, or therapeutic context.Inside, you will:Understand the MASLD, MASH, MetALD, and steatotic liver disease terminology now used across current clinical literature.Navigate laboratory, serum-based, and imaging-based approaches to fibrosis assessment and specialist referral.Connect insulin resistance, hepatic lipotoxicity, inflammation, and fibrogenesis to real clinical decision-making.Review complications including cirrhosis, portal hypertension, and hepatocellular carcinoma with a practical risk-focused lens.Compare lifestyle therapy, cardiometabolic intervention, resmetirom, incretin-based therapies, and emerging pharmacologic options.Apply a multidisciplinary perspective that links hepatology, endocrinology, internal medicine, primary care, and cardiovascular risk reduction.Designed for hepatology and gastroenterology fellows, internists, endocrinologists, primary care clinicians, advanced practice providers, and senior medical learners, this book offers a clear pathway through one of the most important updates in modern metabolic liver medicine. Its structure supports quick orientation, deeper study, and professional review across both diagnostic and therapeutic chapters.If you want a current, clinically grounded reference for understanding and explaining metabolic dysfunction-associated steatotic liver disease, this book is designed to help you study the field with clarity, structure, and professional confidence. Read more

ASIN B0H1LPPB3D
ISBN13 979-8196630262
Language English
Publisher Independently published
Dimensions 8.5 x 1.19 x 11 inches
Item Weight 3.27 pounds
Print length 527 pages
Publication date May 12, 2026

Correction of product information

If you notice any omissions or errors in the product information on this page, please use the correction request form below.

Correction Request Form

Customer ratings & reviews

5 out of 5
★★★★★
132 ratings | 54 reviews
How item rating is calculated
View all reviews
5 stars
90% (119)
4 stars
0% (0)
3 stars
0% (0)
2 stars
0% (0)
1 star
10% (13)
Sort by

There are currently no written reviews for this product.